Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency.

Luff JA, Yuan H, Kennedy D, Schlegel R, Felsburg P, Moore PF.

PLoS One. 2014 Jul 15;9(7):e102033. doi: 10.1371/journal.pone.0102033. eCollection 2014.

2.

Canine keratinocytes upregulate type I interferons and proinflammatory cytokines in response to poly(dA:dT) but not to canine papillomavirus.

Luff JA, Yuan H, Suter MM, Müller EJ, Schlegel R, Moore PF.

Vet Immunol Immunopathol. 2013 Jun 15;153(3-4):177-86. doi: 10.1016/j.vetimm.2013.02.001. Epub 2013 Mar 5.

3.

Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs.

Goldschmidt MH, Kennedy JS, Kennedy DR, Yuan H, Holt DE, Casal ML, Traas AM, Mauldin EA, Moore PF, Henthorn PS, Hartnett BJ, Weinberg KI, Schlegel R, Felsburg PJ.

J Virol. 2006 Jul;80(13):6621-8.

4.

Canine X-linked severe combined immunodeficiency.

Felsburg PJ, Hartnett BJ, Henthorn PS, Moore PF, Krakowka S, Ochs HD.

Vet Immunol Immunopathol. 1999 Aug 2;69(2-4):127-35.

PMID:
10507300
5.

Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.

Felsburg PJ, Somberg RL, Hartnett BJ, Suter SF, Henthorn PS, Moore PF, Weinberg KI, Ochs HD.

Blood. 1997 Oct 15;90(8):3214-21.

6.

B-cell function in canine X-linked severe combined immunodeficiency.

Hartnett BJ, Somberg RL, Krakowka S, Ochs HD, HogenEsch H, Moore PF, Weinberg KI, Felsburg PJ.

Vet Immunol Immunopathol. 2000 Jun 30;75(1-2):121-34.

PMID:
10889304
7.

Bone marrow transplantation for canine X-linked severe combined immunodeficiency.

Hartnett BJ, Henthorn PS, Moore PF, Weinberg KI, Ochs HD, Felsburg PJ.

Vet Immunol Immunopathol. 1999 Aug 2;69(2-4):137-44.

PMID:
10507301
8.

Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency.

Chinen J, Davis J, De Ravin SS, Hay BN, Hsu AP, Linton GF, Naumann N, Nomicos EY, Silvin C, Ulrick J, Whiting-Theobald NL, Malech HL, Puck JM.

Blood. 2007 Jul 1;110(1):67-73. Epub 2007 Mar 16.

9.

T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation.

Vernau W, Hartnett BJ, Kennedy DR, Moore PF, Henthorn PS, Weinberg KI, Felsburg PJ.

Biol Blood Marrow Transplant. 2007 Sep;13(9):1005-15. Epub 2007 Aug 2.

10.

Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes.

Whitwam T, Haskins ME, Henthorn PS, Kraszewski JN, Kleiman SE, Seidel NE, Bodine DM, Puck JM.

Blood. 1998 Sep 1;92(5):1565-75.

11.

Postnatal development of T cells in dogs with X-linked severe combined immunodeficiency.

Somberg RL, Tipold A, Hartnett BJ, Moore PF, Henthorn PS, Felsburg PJ.

J Immunol. 1996 Feb 15;156(4):1431-5.

PMID:
8568244
12.

Thymopoiesis and T cell development in common gamma chain-deficient dogs.

Felsburg PJ, Hartnett BJ, Gouthro TA, Henthorn PS.

Immunol Res. 2003;27(2-3):235-46. Review.

PMID:
12857971
13.

Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.

Hartnett BJ, Yao D, Suter SE, Ellinwood NM, Henthorn PS, Moore PE, McSweeney PA, Nash RA, Brown JD, Weinberg KI, Felsburg PJ.

Biol Blood Marrow Transplant. 2002;8(4):188-97.

PMID:
12014808
14.

Gene therapy studies in a canine model of X-linked severe combined immunodeficiency.

Felsburg PJ, De Ravin SS, Malech HL, Sorrentino BP, Burtner C, Kiem HP.

Hum Gene Ther Clin Dev. 2015 Mar;26(1):50-6. doi: 10.1089/humc.2015.004. Epub 2015 Feb 24. Review.

15.

Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model.

Suter SE, Gouthro TA, O'Malley T, Hartnett BJ, McSweeney PA, Moore PF, Felsburg PJ, Haskins ME, Henthorn PS.

Vet Immunol Immunopathol. 2007 Jun 15;117(3-4):183-96. Epub 2007 Mar 23.

PMID:
17442404
16.

T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency.

Somberg RL, Robinson JP, Felsburg PJ.

J Immunol. 1994 Nov 1;153(9):4006-15.

PMID:
7930609
17.

Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras.

Tsai EJ, Malech HL, Kirby MR, Hsu AP, Seidel NE, Porada CD, Zanjani ED, Bodine DM, Puck JM.

Blood. 2002 Jul 1;100(1):72-9.

18.

Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome.

Wada T, Yasui M, Toma T, Nakayama Y, Nishida M, Shimizu M, Okajima M, Kasahara Y, Koizumi S, Inoue M, Kawa K, Yachie A.

Blood. 2008 Sep 1;112(5):1872-5. doi: 10.1182/blood-2008-04-149708. Epub 2008 Jun 16.

19.

Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone.

De Ravin SS, Shum E, Zarember KA, Rezvani G, Rosenfeld RG, Stratakis CA, Malech HL.

J Pediatr Endocrinol Metab. 2008 Nov;21(11):1057-63.

20.

Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.

Kennedy DR, Hartnett BJ, Kennedy JS, Vernau W, Moore PF, O'Malley T, Burkly LC, Henthorn PS, Felsburg PJ.

Vet Immunol Immunopathol. 2011 Jul 15;142(1-2):36-48. doi: 10.1016/j.vetimm.2011.04.003. Epub 2011 Apr 14.

Supplemental Content

Support Center